Project Grant R35GM162228
- Federal Grant Award Summary The University of Southern California received a $395,200 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025 through August 31, 2030. This five-year research initiative focuses on developing novel computational methods to analyze population genomics data across global human populations, with particular emphasis on inferring complex...
- Federal Grant Award Summary The University of Southern California received a $451,259 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through June 30, 2029. This award supports fundamental research investigating heterochromatin repair mechanisms from a chromatin perspective. The project will deliver scientific research outputs focused on understanding how...
- Federal Grant Award Summary The University of Southern California received a $656,500 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective April 1, 2026 through January 31, 2031. The award supports research to develop and apply innovative technologies for controlling cell differentiation and patterning in multicellular development, using a multilayered arterial wall as a case...
- Federal Grant Award Summary The University of Southern California received a $2.28 million Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded September 1, 2025, with completion targeted for August 31, 2029. The award funds fundamental biomedical research investigating protein aggregation mechanisms controlled by disaggregases—biological molecules including macromolecular chaperones,...
- Federal Grant Award Summary The University of Southern California received a $456,500 Project Grant from the National Institute of General Medical Sciences under the Biomedical Research and Research Training program (CFDA 93.859), awarded February 15, 2026, with completion targeted for December 31, 2030. This five-year research initiative investigates the mechanism and function of XIST, a long non-coding RNA (lncRNA), in maintaining X chromosome inactivation (XCI)—the epigenetic silencing...
- Federal Project Grant Award Summary The University of Southern California received a $413,300 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded August 15, 2025, with completion targeted for July 31, 2030. The grant funds research investigating three critical areas of human genetics: the role of natural selection in shaping genetic architecture of complex traits, gene-environment...
- Federal Grant Award Summary The University of Southern California received a $351,920 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through August 31, 2030. This five-year award supports fundamental basic research investigating the cellular and molecular determinants of regenerative capabilities in amniotes, with particular focus on understanding...
- Federal Grant Award Summary The University of Southern California received a $456,500 Project Grant award from the National Institute of General Medical Sciences under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through July 31, 2030. The grant supports fundamental research into the structural and biosynthetic mechanisms of modular polyketide synthases (PKS), which are enzymatic assembly lines used by microorganisms to produce complex small...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded University of California, Irvine a $380,540 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) effective September 1, 2025, through June 30, 2030. This award supports a comprehensive research program investigating epigenetic regulation mechanisms in human embryonic stem cell (hESC) lineage specification and early differentiation. The research utilizes...
- Federal Grant Award Summary The University of Chicago received a $451,000 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded March 1, 2026, with completion targeted for February 28, 2031. This five-year grant funds the development of novel statistical methodologies designed to link genetic variants identified through genome-wide association studies (GWAS) to underlying regulatory...
The University of Southern California received a $589,500 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective May 1, 2026 through January 31, 2031. Dr. Li's laboratory will conduct computational research to interrogate epigenetic regulation in cellular plasticity and heterogeneity, addressing critical gaps in understanding how epigenetic modifications and chromatin organization influence transcriptional regulatory programs and cell fate determination. The project focuses on developing advanced computational tools to comprehensively assess allele-specific and functional epigenetic heterogeneity across the complete genome, including previously unmapped genomic regions, and aims to complete epigenetic annotation of the mouse genome using recently released telomere-to-telomere reference sequences. The research combines advanced genome technologies and computational biology methodologies to dissect the functional roles of epigenetic regulators in mediating 5-methylcytosine (5MC) plasticity and heterogeneity. This work addresses significant research challenges in understanding how changes in the epigenome and chromatin organization can alter transcriptional regulatory programs and cell differentiation status. The project will generate computational tools, analytical methodologies, and genomic annotation resources that advance fundamental understanding of epigenetic regulation mechanisms underlying cell fate determination processes.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $589.5k | 4/17/26 |